{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-034341","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2023-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.694003+00:00","generated_at":"2026-06-07T13:28:59.308838+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Genprex enters $25M at-the-market offering with H.C. Wainwright; ends JMP deal","bullets":["ATM offering allows sale of up to $25 million of common stock through H.C. Wainwright & Co. on Nasdaq.","Agent commission set at 3% of gross sales proceeds; Company retains customary indemnification rights.","Terminated Equity Distribution Agreement with JMP Securities LLC, effective December 13, 2023.","Offering conducted under existing effective S-3 registration statement filed April 2023.","No escrow or trust arrangement required; sales at Company's discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-034341","json":"https://secwatch.observer/filing/0001437749-23-034341.json","markdown":"https://secwatch.observer/filing/0001437749-23-034341.md","text":"https://secwatch.observer/filing/0001437749-23-034341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923034341/0001437749-23-034341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923034341/gnpx20231121_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:28:59.308838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d339ac1352ada8371e7acb4129c64c8d9d545ae4","claim":"Genprex, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $25.0 million (effective 2023-12-13).","evidence_excerpt":"On December 13, 2023, Genprex, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC, serving as agent (the “Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $25.0 million (the “Shares”) through the Agent (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923034341/0001437749-23-034341-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"up to $25.0 million"},{"label":"Effective","value":"2023-12-13"}],"fact_type":"material_agreement"},{"claim_id":"e6b012e114d745d956bd1dd27b784946e318a2a7","claim":"Genprex, Inc. terminated Equity Distribution Agreement with JMP Securities LLC (effective 2023-12-12).","evidence_excerpt":"On December 12, 2023, the Company provided notice of its termination of the Equity Distribution Agreement, dated as of November 18, 2022 (the “Equity Distribution Agreement”), by and between the Company and JMP Securities LLC.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923034341/0001437749-23-034341-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"JMP Securities LLC"},{"label":"Effective","value":"2023-12-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}